-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $54

Benzinga·09/08/2026 12:24:00
語音播報
BMO Capital analyst David Lebowitz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $61 to $54.